Polygenic risk scores (PRS) did not predict the development of cannabis use disorder (CUD) in patients with schizophrenia and other psychiatric disorders, according to results from a study published in Psychological Medicine. Researchers conducted a case-control study to examine the associations between PRS for schizophrenia and other mental disorders with the development of…